These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1296037)

  • 1. The serum ferrokinetics in Parkinson's disease.
    Chen WH; Shih PY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Nov; 8(11):581-4. PubMed ID: 1296037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
    Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR
    PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered systemic iron metabolism in Parkinson's disease.
    Logroscino G; Marder K; Graziano J; Freyer G; Slavkovich V; LoIacono N; Cote L; Mayeux R
    Neurology; 1997 Sep; 49(3):714-7. PubMed ID: 9305329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower hemoglobin levels in patients with parkinson's disease are associated with disease severity and iron metabolism.
    Deng Q; Zhou X; Chen J; Pan M; Gao H; Zhou J; Wang D; Chen Q; Zhang X; Wang Q; Xu Y
    Brain Res; 2017 Jan; 1655():145-151. PubMed ID: 27840188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic iron metabolism and mortality from Parkinson's disease.
    Marder K; Logroscino G; Tang MX; Graziano J; Cote L; Louis E; Alfaro B; Mejia H; Slavkovich V; Mayeux R
    Neurology; 1998 Apr; 50(4):1138-40. PubMed ID: 9566409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary and serum iron, body iron stores and coronary heart disease.
    Gupta R; Rastogi S; Nagar R; Kastia S; Kaul V
    J Assoc Physicians India; 2000 May; 48(5):489-92. PubMed ID: 11273140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral iron metabolism in patients with Parkinson's disease.
    Cabrera-Valdivia F; Jiménez-Jiménez FJ; Molina JA; Férnandez-Calle P; Vázquez A; Cañizares-Liébana F; Larumbe-Lobalde S; Ayuso-Peralta L; Rabasa M; Codoceo R
    J Neurol Sci; 1994 Aug; 125(1):82-6. PubMed ID: 7964893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total iron binding capacity or transferrin concentration alone outperforms iron and saturation indices in predicting iron deficiency.
    Hawkins RC
    Clin Chim Acta; 2007 May; 380(1-2):203-7. PubMed ID: 17376421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk.
    Costa-Mallen P; Zabetian CP; Agarwal P; Hu SC; Yearout D; Samii A; Leverenz JB; Roberts JW; Checkoway H
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1087-92. PubMed ID: 26228081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased ferritin levels in brain in Parkinson's disease.
    Dexter DT; Carayon A; Vidailhet M; Ruberg M; Agid F; Agid Y; Lees AJ; Wells FR; Jenner P; Marsden CD
    J Neurochem; 1990 Jul; 55(1):16-20. PubMed ID: 2355217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of serum ferritin levels in the assessment of iron status in non-pregnant Zairean women of childbearing age.
    Kuvibidila S; Yu L; Warrier RP; Ode D; Mbele V
    J Trop Med Hyg; 1994 Jun; 97(3):171-9. PubMed ID: 8007058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost effective approach to the biochemical diagnosis of iron deficiency.
    Shek CC; Swaminathan R
    J Med; 1990; 21(6):313-22. PubMed ID: 2128750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression.
    Ikeda K; Nakamura Y; Kiyozuka T; Aoyagi J; Hirayama T; Nagata R; Ito H; Iwamoto K; Murata K; Yoshii Y; Kawabe K; Iwasaki Y
    Neurodegener Dis; 2011; 8(4):252-8. PubMed ID: 21282940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease.
    Tórsdóttir G; Kristinsson J; Sveinbjörnsdóttir S; Snaedal J; Jóhannesson T
    Pharmacol Toxicol; 1999 Nov; 85(5):239-43. PubMed ID: 10608487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the change in the levels of serum ferritin, serum iron and total iron binding capacity caused by aging and sex difference].
    Ueno Y; Fujita K; Takashina N; Chiba S; Uzuka Y; Kinouchi T; Shimizu N
    Rinsho Byori; 1991 May; 39(5):523-30. PubMed ID: 2072576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's Disease is Accompanied by Intertwined Alterations in Iron Metabolism and Activated Immune-inflammatory and Oxidative Stress Pathways.
    de Farias CC; Maes M; Bonifacio KL; Matsumoto AK; Bortolasci CC; Nogueira AS; Brinholi FF; Morimoto HK; de Melo LB; Moreira EG; Barbosa DS
    CNS Neurol Disord Drug Targets; 2017; 16(4):484-491. PubMed ID: 28240188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fe and Cu do not differ in Parkinson's disease: a replication study plus meta-analysis.
    Mariani S; Ventriglia M; Simonelli I; Donno S; Bucossi S; Vernieri F; Melgari JM; Pasqualetti P; Rossini PM; Squitti R
    Neurobiol Aging; 2013 Feb; 34(2):632-3. PubMed ID: 22738721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dose-effect of the administration of ferrous fumarate in aged persons with iron deficiency].
    Lares-Asseff I; Pérez MG; López MC; Romero L; Camacho GA; Toledo A; Guillé AJ; Trujillo F; Juárez H; Flores J
    Rev Gastroenterol Mex; 1999; 64(4):159-66. PubMed ID: 10851577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum ferritin, erythrocyte protoporphyrin and transferrin saturation in Mauritanian free living children.
    Galan P; Etard JF; Borel E; Debenaze C; Hercberg S
    Int J Vitam Nutr Res; 1989; 59(2):214-8. PubMed ID: 2777506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum pro-oxidant and antioxidant factors and risk of Parkinson's disease: population study].
    Molina-Arjona JA; de Bustos F; Benito-León J; Jiménez-Jiménez FJ; Rodríguez J; Trincado R; Porta-Etessan J; Vega S; Bermejo F
    Rev Neurol; 1999 Jul 1-15; 29(1):12-5. PubMed ID: 10528302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.